Home
Product
Pipeline
Team
Educational material
News
Contact
General
SXM CSO, Dr. Ardjan van der Linden, will present scientific and clinical results of KAIROS at ECCMID 2024.
Mar 5, 2024
General
A fresh, up-to-date website goes live. Today we introduce the latest developments of KAIROS and overall SXM.
Mar 4, 2024
General
SXM finishes clinical study at the Erasmus Medical Center (NL). KAIROS demonstrates excellent clinical performance with results being in preparation for dissemination.
Feb 29, 2024
General
SXM CEO, Dr Sophia E. Shanko, invited to speak at the Stakeholder Meeting on “Innovative Antimicrobial Therapy Development”
Jan 30, 2024
General
2024 finds us with a team of 12 highly driven professionals including engineers, scientists, regulatory expertise and business developers.
Jan 1, 2024
General
SXM has raised cumulative EUR2.7mln in granted projects from the Eindhoven region, the Dutch Government and the European Commission.
Dec 21, 2023
1
2
3
Next